EuEndo_contents_Layout 1 04/09/2009 11:35 Page 7
Contents
Contents
Diabetes and Cardiovascular Risk
Cardiovascular Risk in Type 2 Diabetes – Reflecting on the ADVANCE Study 42
Sophia Zoungas,
1
John Chalmers
2
and Anushka Patel
3
1. Senior Research Fellow, Cardiovascular and Renal Divisiosn, The George Institute for International Health,
University of Sydney, and School of Public Health, Monash University, Melbourne; 2. Director, Professorial Unit,
The George Institute for International Health, University of Sydney; 3. Director, Cardiovascular Division,
The George Institute for International Health, University of Sydney
Pituitary Disorders
The Role of Recombinant Human Growth Hormone Biosimilars in the
Management of Growth Disorders 47
Tomasz E Romer
Endocrinologist, Private Practice, Warsaw
Advances in Our Understanding of Acromegaly – Is There an Optimal Management Regimen? 51
Claire E Higham
1
and Peter J Trainer
2
1. Diabetes and Endocrinology Specialist Registrar; 2. Consultant Endocrinologist, Department of Endocrinology,
Christie Hospital, Manchester
Familial Isolated Pituitary Adenomas 55
Harvinder S Chahal,
1
VK Ajith Kumar
2
and Márta Korbonits
3
1. Specialist Registrar in Endocrinology, Centre for Endocrinology, Barts and the London Medical School;
2. Consultant in Clinical Genetics, Clinical Genetics Department, Great Ormond Street Hospital;
3. Professor of Endocrinology and Metabolism, Centre for Endocrinology, Barts and the London Medical School
Thyroid Disorders
Guideline-orientated Diagnosis of Thyroid Nodules 59
Ralf Paschke,
1
Enrico Papini
2
and Hossein Gharib
3
1. Professor of Internal Medicine and Endocrinology, III Medical Department, University of Leipzig;
2. Professor of Endocrinology, University of Rome ‘La Sapienza’ Medical School; 3. Professor of Medicine,
Division of Endocrinology, Diabetes, Metabolism and Nutrition, Mayo Clinic College of Medicine
Consequences of the Use of Low Blood-spot Thyroid-stimulating Hormone
Cut-offs for the Neonatal Screening of Congenital Hypothyroidism 64
Luca Persani
1
and Davide Calebiro
2
1. Associate Professor of Endocrinology; 2. Post-doctoral Research Fellow, Department of Medical Sciences,
University of Milan, and Laboratory of Experimental Endocrinology, IRCCS Istituto Auxologico Italiano
Parathyroid Disorders
Focus on Primary Hyperparathyroidism – Diagnosis, Management and the Role of Calcimimetics 67
Satellite Symposium: ‘Optimal Management of Primary Hyperparathyroidism: What Is the Latest Evidence?’
Held during the 11th European Congress of Endocrinology on 26 April 2009, Istanbul, Turkey
Erectile Dysfunction
Prelox
®
for Improvement of Erectile Quality 70
Steven Lamm
Clinical Assistant Professor of Medicine, New York University School of Medicine
Diabetes-associated Erectile Dysfunction 75
Pedro Vendeira,
1,2
Carla Costa
2,3,4
and Ronald Virag
5
1. Department of Urology, S. João Central Hospital, Porto; 2. Association for the Advanced Study of Human Sexuality (iSEX);
3. Department of Biochemistry, Faculty of Medicine, University of Porto; 4. Laboratory for Molecular Cell Biology,
Faculty of Medicine, University of Porto; 5. Centre d’Explorations et Traitements de l’Impuissance, Paris
EUROPEAN ENDOCRINOLOGY 7
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87